Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Efficacy of Alpha-Lipoic Acid in Improving Oxidative, Inflammatory, and Mood Status in Women With Episodic Migraine in a Randomised, Double-Blind, Placebo-Controlled Clinical Trial Publisher Pubmed



Rezaei Kelishadi M1 ; Alavi Naeini A1 ; Askari G1 ; Khorvash F2 ; Heidari Z3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Biostatistics and Epidemiology, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran

Source: International Journal of Clinical Practice Published:2021


Abstract

Aim: Migraine is a common neurovascular disorder, which is associated with severe to moderate disabling headaches. Oxidative stress and inflammation might play a role in migraine pathogenesis and the mood disorders. Considering the antioxidant and anti-inflammatory properties of alpha-lipoic acid (ALA), this study was designed to investigate its effect on oxidative, inflammatory, and mood conditions in women with episodic migraine. Methods: In total, 92 women with episodic migraine participated in the study. The patients were randomly divided into two groups, receiving a 300-mg capsule of ALA or placebo twice daily for 3 months. To assess the oxidative and inflammatory status, the serum levels of total antioxidant capacity (TAC), total oxidant status (TOS), glutathione (GSH), malondialdehyde (MDA), oxidative stress index (OSI), and C-reactive protein (CRP) were determined at the beginning and at the end of the intervention. A depression, anxiety, stress scale (DASS-21-items) questionnaire was used to evaluate mood status. Results: Finally, 79 patients reached the final analysis stage. At the end of the intervention, a significant decrease in the serum levels of MDA (means difference [MD]: −0.83, 95% confidence intervals (CI): −1.04, −0.62 nmol/mL vs MD: −0.32, CI: −0.48, −0.15 nmol/mL; P <.001) and CRP (MD: −0.78, CI: −1.17, −0.39 mg/L vs MD: −0.63, CI: −1.80, 0.52 mg/L; P <.001) was observed in the ALA as compared with the placebo group, but changes in serum GSH (P =.086), TAC (P =.068), TOS (P =.225), and OSI (P =.404) were not statistically significant. In addition, depression, anxiety, and stress (with P <.001, in all cases) had significantly decreased in the intervention as compared with the control group. Conclusion: The results of this study suggest that ALA supplementation for 3 months has beneficial effects on improving the oxidative, inflammatory, and mood conditions of patients suffering from episodic migraine. © 2021 John Wiley & Sons Ltd
Experts (# of related papers)
Other Related Docs
25. L-Carnitine Versus Propranolol for Pediatric Migraine Prophylaxis, Iranian Journal of Child Neurology (2021)
45. Vitamin D Status in Migraine Patients: A Case-Control Study, BioMed Research International (2014)